Subscribe

Topic: Seattle blog main

New with Topic: Seattle blog main


Xconomy
Xconomy posted a blog entry
Naverus, a Company That Makes Flight Paths Greener, Gets Acquired by GE
Kent, WA-based Naverus, which develops navigation technologies for airplanes, has been acquired by GE Aviation, a...
 
Xconomy
Xconomy posted a blog entry
Do Seattle Startups Care Too Much About Retail, Too Little About Building a Huge Audience?
Oh no you didn’t. Come on, Andrew Chen, you know better than to call out Seattle tech startups for not producing a...
 
Xconomy
Xconomy posted a blog entry
Google Demos Chrome OS, Microsoft Links Into LinkedIn, Amazon Ramps Up for Holidays, & More Big Company News
It’s been a busy week around here for the big tech companies. At Xconomy, we don’t usually report on things like...
 
Xconomy
Xconomy posted a blog entry
RealSelf, Backed by Second Avenue and Rich Barton, Blazes Trail with Cosmetic Review Site
Who says consumer websites are dead? Maybe you don’t need the ridiculous traffic of, say, Seattle-based Cheezburger...
 
Xconomy
Xconomy posted a blog entry
Paul Allen Diagnosed with Cancer
[Updated 11/16/09 6pm. See below] Microsoft co-founder and renowned technologist Paul Allen has been diagnosed with...
 
Xconomy
Xconomy posted a blog entry
Trubion CEO Peter Thompson Steps Down, Arch’s Gillis To Step Up Temporarily
[Updated: 5:55 pm Pacific, 11/16/09] Trubion Pharmaceuticals, the Seattle-based company developing new drugs for autoimmune...
 
Xconomy
Xconomy posted a blog entry
Fate Therapeutics Bags $30M Venture Deal, Led by OVP, to Develop “Industrialized” Stem Cells
Fate Therapeutics, the San Diego-based company on a quest to develop techniques that make stem cell research practical for the...
 
Xconomy
Xconomy posted a blog entry
Avnera Raises $8M Equity Round to Advance Wireless Audio Chip Technology
A consumer tech company has scored one of the bigger equity financing rounds in the Portland area this fall. Beaverton,...
 
Xconomy
Xconomy posted a blog entry
Seattle’s Bill McCoy, E-Books and Digital Distribution Expert, Leaving Adobe
We’ve all been wondering how the Adobe layoffs, reported earlier this week, may affect the Seattle area—especially...
 
Xconomy
Xconomy posted a blog entry
Enroute Closes Series A, Looks for More as It Expands and Aims for Profitability
Early-stage tech financings are still chugging along, it seems. On the heels of yesterday’s news of a $5.25 million financing...
 
Xconomy
Xconomy posted a blog entry
Alder’s Breakout $1B Deal, Kineta Teams With UW on Vaccines, Verathon Gets Acquired, & More Seattle-Area Life Sciences News
This was the week that a little biotech company in Bothell that few of the locals have ever heard of, burst onto the national...
 
Xconomy
Xconomy posted a blog entry
Future of Search Event Nov. 30 to Draw Top Startups, VCs, and Execs to UW
Online search and information discovery are being transformed before our eyes. It’s no longer just Google, or Google and...
 
Xconomy
Xconomy posted a blog entry
Alder and New Partner, Bristol, to Give Amgen and Abbott a Run for Their Money
Alder Biopharmaceuticals keeps such a low profile that even after five years in business, few people in Seattle biotech know...
 
Xconomy
Xconomy posted a blog entry
Seattle’s Kineta Rakes in Half of $13M Federal Contract to UW For Vaccine Boosters
Kineta, the Seattle-based developer of drugs for autoimmune diseases, has won about half of a $13 million federal contract...
 
Xconomy
Xconomy posted a blog entry
Where Are the Software Deals? WA Firms Raised $70M in October, Mostly in Healthcare, Gaming
Early-stage software and IT deals are a scarce breed these days. That’s my initial take from looking at the October funding...
 
Xconomy
Xconomy posted a blog entry
San Diego’s PaxVax Developing Oral Tablet Vaccine, Looks to Raise More Cash With Support of Seattle’s Ignition Capital
PaxVax, a San Diego startup backed by Seattle’s Ignition Capital, has raised $2 million of a planned $6 million investment...
 
Xconomy
Xconomy posted a blog entry
Porn Always Wins, Bacon Salt Expands, and Other Thoughts from Entrepreneur University
I’m not going to do justice to this event. Let’s just get that out there right now. There were some great speakers and...
 
Xconomy
Xconomy posted a blog entry
Elias Zerhouni Talks Public Health Challenges, Culture Wars at WBBA Annual Meeting
Just came back from the Washington Biotechnology & Biomedical Association’s annual meeting in downtown Seattle, where...
 
Xconomy
Xconomy posted a blog entry
Is it Real or Is It High Dynamic Range? How Software Is Changing the Way We Look at Photographs
You know how listening to music on a friend’s pricey Bose headphones makes it harder to tolerate your tinny little...
 
Xconomy
Xconomy posted a blog entry
A Tale of Three Cities: How Boston, Boulder, and Seattle Measure Up as Tech Innovation Hubs
I was chatting with a couple of local investors at the TechStars (seed fund and mentorship program) event in Seattle on...
 
BostonDave
BostonDave shared an item
Microsoft’s New Head of FUSE Labs, Lili Cheng, on Strategy, Social Computing, and Bicoastal Life
Software, people, social media Gregory T. Huang wrote: Microsoft’s latest reorganization, which involves labs in both the Seattle and Boston areas, has a new face. It’s Lili Cheng, a 14-year Microsoftie with experience in both research...
 
Xconomy
Xconomy posted a blog entry
Omeros, First U.S. Biotech IPO Since February 2008, Sees Shares Drop 13 Percent in First Day
Shares of Seattle-based Omeros, the first true U.S. biotech company to go public in more than 18 months, dropped about 13...
 
Xconomy
Xconomy posted a blog entry
Fundraising Tide Remains Low for Venture Capital Firms
Fundraising by U.S. venture capital firms continues to lag. A survey released overnight by Dow Jones Private Equity Analyst...
 
Xconomy
Xconomy posted a blog entry
Glympse and TravellingWave Step Out, Microsoft Does Voice Search, and More Mobile News
It’s been a very busy week for news in the mobile industry. First, Amazon (NASDAQ: AMZN) rolled out a one-click mobile...
 
Xconomy
Xconomy posted a blog entry
Omeros Made Errors on NIH Grant, But Feds Accepted Internal Investigation Saying They Weren’t Overbilled
Omeros, the Seattle biotech company accused by its former chief financial officer of filing false time records on grant work...
 
Xconomy
Xconomy posted a blog entry
On Verge of Omeros IPO, Former Finance Chief Accuses Company of Filing False Records with NIH
Seattle-based Omeros, the biotech company attempting to raise as much as $80 million in an initial public offering slated for...
 
Xconomy
Xconomy posted a blog entry
Omeros Teed Up for IPO Next Week, Seeking to Rake In More Than $80M
Seattle-based Omeros is on the docket to go public next week, and will attempt to become the first pure-play biotechnology...
 
Xconomy
Xconomy posted a blog entry
How to Launch a Professional-Looking Blog on a Shoestring
Maybe you’d like to have a sleek, attractive blog or website for yourself or your business. Maybe you’ve looked...
 
Xconomy
Xconomy posted a blog entry
The Web Has Feelings Too—and Seattle Startups Will Tell You What They Are
Laugh, and the world laughs with you. Weep, and you weep alone (as the old saying goes). Or maybe not. Maybe no one weeps alone...
 
Xconomy
Xconomy posted a blog entry
Spiration Pulls in $7M Debt Financing For Device to Treat Lung Diseases
Spiration, the Redmond, WA-based maker of a device to treat deadly lung diseases like emphysema and chronic bronchitis, has...
 
Xconomy
Xconomy posted a blog entry
Founder’s Co-op Funds Nearlyweds and BigDoor Media, and Is Exploring New Investment Model
Seattle-based Founder’s Co-op, the seed-stage fund run by Andy Sack and Chris DeVore, has been busy as of late. The...
 
Xconomy
Xconomy posted a blog entry
Top 10 Takeaways from WTIA’s Healthcare-IT Event: Follow the Money, Startup Opps, & More
The role of information technology in healthcare reform is such a huge, sprawling topic that it’s hard to make any real...
 
Xconomy
Xconomy posted a blog entry
Dendreon to Turn in Provenge Application to FDA in Mid-November
Dendreon has been saying for months that it plans to file its amended application to the FDA in the fourth quarter, and today...